Sei Investments Co. Boosts Stock Holdings in Colgate-Palmolive (NYSE:CL)

Sei Investments Co. grew its holdings in Colgate-Palmolive (NYSE:CL) by 1.8% during the second quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 609,139 shares of the company’s stock after acquiring an additional 10,500 shares during the period. Sei Investments Co. owned about 0.07% of Colgate-Palmolive worth $59,111,000 as of its most recent SEC filing.

Other hedge funds have also made changes to their positions in the company. Gryphon Financial Partners LLC acquired a new position in shares of Colgate-Palmolive in the 4th quarter valued at about $225,000. Cambridge Investment Research Advisors Inc. boosted its holdings in shares of Colgate-Palmolive by 6.1% in the 4th quarter. Cambridge Investment Research Advisors Inc. now owns 184,902 shares of the company’s stock valued at $14,739,000 after buying an additional 10,589 shares during the period. TCW Group Inc. acquired a new position in shares of Colgate-Palmolive in the 4th quarter valued at about $1,428,000. Orion Portfolio Solutions LLC boosted its holdings in shares of Colgate-Palmolive by 13.2% in the 4th quarter. Orion Portfolio Solutions LLC now owns 50,526 shares of the company’s stock valued at $4,062,000 after buying an additional 5,888 shares during the period. Finally, HCR Wealth Advisors acquired a new position in shares of Colgate-Palmolive in the 4th quarter valued at about $218,000. Hedge funds and other institutional investors own 80.41% of the company’s stock.

Insider Transactions at Colgate-Palmolive

In related news, Director Martina Hundmejean sold 2,313 shares of the business’s stock in a transaction that occurred on Friday, August 23rd. The shares were sold at an average price of $103.86, for a total transaction of $240,228.18. Following the transaction, the director now directly owns 11,755 shares of the company’s stock, valued at $1,220,874.30. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. In related news, EVP Gregory Malcolm sold 10,533 shares of the business’s stock in a transaction that occurred on Tuesday, August 6th. The shares were sold at an average price of $103.10, for a total transaction of $1,085,952.30. Following the transaction, the executive vice president now directly owns 10,377 shares of the company’s stock, valued at $1,069,868.70. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, Director Martina Hundmejean sold 2,313 shares of the business’s stock in a transaction that occurred on Friday, August 23rd. The shares were sold at an average price of $103.86, for a total transaction of $240,228.18. Following the transaction, the director now directly owns 11,755 shares in the company, valued at $1,220,874.30. The disclosure for this sale can be found here. Insiders have sold a total of 43,490 shares of company stock valued at $4,486,063 over the last ninety days. Corporate insiders own 0.34% of the company’s stock.

Wall Street Analysts Forecast Growth

Several analysts recently weighed in on CL shares. Wells Fargo & Company downgraded shares of Colgate-Palmolive from an “equal weight” rating to an “underweight” rating and set a $100.00 price objective on the stock. in a research report on Monday, September 16th. Bank of America lifted their price objective on shares of Colgate-Palmolive from $100.00 to $110.00 and gave the company a “buy” rating in a research report on Wednesday, July 10th. Hsbc Global Res downgraded shares of Colgate-Palmolive from a “strong-buy” rating to a “hold” rating in a research report on Friday, July 26th. Redburn Atlantic upgraded shares of Colgate-Palmolive to a “hold” rating in a research report on Thursday, August 1st. Finally, Stifel Nicolaus lifted their price objective on shares of Colgate-Palmolive from $95.00 to $105.00 and gave the company a “buy” rating in a research report on Monday, July 22nd. One research analyst has rated the stock with a sell rating, eight have assigned a hold rating and thirteen have issued a buy rating to the stock. According to data from MarketBeat, Colgate-Palmolive presently has an average rating of “Moderate Buy” and an average price target of $103.83.

Colgate-Palmolive Stock Performance

Colgate-Palmolive stock opened at $103.06 on Monday. The firm’s 50 day simple moving average is $102.71 and its 200-day simple moving average is $95.89. The company has a market cap of $84.55 billion, a P/E ratio of 32.61, a price-to-earnings-growth ratio of 3.72 and a beta of 0.40. The company has a debt-to-equity ratio of 16.90, a current ratio of 1.06 and a quick ratio of 0.70. Colgate-Palmolive has a fifty-two week low of $67.62 and a fifty-two week high of $109.30.

Colgate-Palmolive (NYSE:CL) last released its earnings results on Friday, July 26th. The company reported $0.91 earnings per share for the quarter, topping the consensus estimate of $0.87 by $0.04. The business had revenue of $5.06 billion for the quarter, compared to the consensus estimate of $5 billion. Colgate-Palmolive had a net margin of 14.21% and a return on equity of 470.19%. The firm’s quarterly revenue was up 4.9% compared to the same quarter last year. During the same period last year, the firm posted $0.77 earnings per share. As a group, equities research analysts predict that Colgate-Palmolive will post 3.57 EPS for the current year.

Colgate-Palmolive Dividend Announcement

The company also recently announced a quarterly dividend, which will be paid on Friday, November 15th. Stockholders of record on Friday, October 18th will be given a $0.50 dividend. This represents a $2.00 annualized dividend and a dividend yield of 1.94%. The ex-dividend date is Friday, October 18th. Colgate-Palmolive’s dividend payout ratio (DPR) is currently 63.29%.

About Colgate-Palmolive

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.